Nanobiotix SA
PAR:NANO

Watchlist Manager
Nanobiotix SA Logo
Nanobiotix SA
PAR:NANO
Watchlist
Price: 3.558 EUR -0.56% Market Closed
Market Cap: 168.7m EUR
Have any thoughts about
Nanobiotix SA?
Write Note

Wall Street
Price Targets

NANO Price Targets Summary
Nanobiotix SA

Wall Street analysts forecast NANO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NANO is 12.526 EUR with a low forecast of 9.595 EUR and a high forecast of 16.8 EUR.

Lowest
Price Target
9.595 EUR
170% Upside
Average
Price Target
12.526 EUR
252% Upside
Highest
Price Target
16.8 EUR
372% Upside
Nanobiotix SA Competitors:
Price Targets
7774
Japan Tissue Engineering Co Ltd
147% Upside
1952
Everest Medicines Ltd
21% Downside
ALGEN
Genoway SA
80% Upside
ACLX
Arcellx Inc
26% Upside
LYEL
Lyell Immunopharma Inc
116% Upside
PYXS
Pyxis Oncology Inc
361% Upside
ALNY
Alnylam Pharmaceuticals Inc
26% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
73% Upside

Revenue
Forecast

Revenue Estimate
Nanobiotix SA

For the last 8 years the compound annual growth rate for Nanobiotix SA's revenue is 81%. The projected CAGR for the next 3 years is 17%.

81%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-98%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Nanobiotix SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat

Net Income
Forecast

Net Income Estimate
Nanobiotix SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-49%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NANO's stock price target?
Price Target
12.526 EUR

According to Wall Street analysts, the average 1-year price target for NANO is 12.526 EUR with a low forecast of 9.595 EUR and a high forecast of 16.8 EUR.

What is Nanobiotix SA's Revenue forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Nanobiotix SA's revenue is 81%. The projected CAGR for the next 3 years is 17%.

Back to Top